UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 82

Sortiert nach

Could there be Haemodynamic Stress Effects on Pro-Inflammatory CD14+CD16+ Monocytes during Convective-Diffusive Treatments? A Prospective Randomized Controlled Trial

Blood purification, 2019-01, Vol.47 (4), p.385-394

2019

Volltextzugriff (PDF)

Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical setting

International journal of hematology, 2020-05, Vol.111 (5), p.614-618

2020

Volltextzugriff (PDF)

Prognostic Role of Cell Blood Count in Chronic Myeloid Neoplasm and Acute Myeloid Leukemia and Its Possible Implications in Hematopoietic Stem Cell Transplantation

Diagnostics (Basel), 2022-10, Vol.12 (10), p.2493

2022

Volltextzugriff (PDF)

Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?

Annals of hematology, 2020-07, Vol.99 (7), p.1675-1676

2020

Volltextzugriff (PDF)

High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity

International journal of hematology, 2020-08, Vol.112 (2), p.141-146

2020

Volltextzugriff (PDF)

Multifactorial pathogenesis of COVID‐19‐related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?

Journal of thrombosis and haemostasis, 2020-11, Vol.18 (11), p.3106-3108

2020

Volltextzugriff (PDF)

Defibrotide in the COVID‐19 coagulopathy: What is the timing?

Journal of thrombosis and haemostasis, 2020-11, Vol.18 (11), p.3113-3115

2020

Volltextzugriff (PDF)

A Real-World Study on Clofarabine and Cytarabine Combination in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Mediterranean journal of hematology and infectious diseases, 2019, Vol.11 (1), p.e2019032-e2019032

2019

Volltextzugriff (PDF)

What Unrelated Hematopoietic Stem Cell Transplantation in Thalassemia Taught us about Transplant Immunogenetics

Mediterranean journal of hematology and infectious diseases, 2016, Vol.8 (1), p.e2016048-e2016048

2016

Volltextzugriff (PDF)

The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma

Journal of hematology and oncology, 2016-03, Vol.9 (27), p.26-26, Article 26

2016

Volltextzugriff (PDF)

Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis

Annals of hematology, 2022-04, Vol.101 (4), p.929-931

2022

Volltextzugriff (PDF)

Perls Stain Grade in Bone Marrow Aspirate Correlates with Overall Survival in Low-Risk Myelodysplastic Patients

Acta haematologica, 2021-05, Vol.144 (3), p.332-336

2021

Volltextzugriff (PDF)

Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia

Annals of hematology, 2022, Vol.101 (1), p.227-228

2022

Volltextzugriff (PDF)

Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomy

Annals of hematology, 2022-04, Vol.101 (4), p.749-754

2022

Volltextzugriff (PDF)

Bone Marrow Homing and Engraftment Defects of Human Hematopoietic Stem and Progenitor Cells

Mediterranean journal of hematology and infectious diseases, 2017-04, Vol.9 (1), p.e2017032-e2017032

2017

Volltextzugriff (PDF)

Combination Therapy with Ruxolitinib and Hydroxyurea for the Treatment of Myeloid-Predominant Leukocytosis in a Patient with Myelofibrosis

Acta haematologica, 2018-01, Vol.139 (3), p.164-165

2018

Volltextzugriff (PDF)

Rituximab Monotherapy or in Combination with Bendamustine Is Not Inferior to Rituximab-CHOP Regimen in the Treatment of Patients with Splenic Marginal Zone Lymphoma in the Real Life

Acta haematologica, 2021-05, Vol.144 (3), p.322-326

2021

Volltextzugriff (PDF)

Predictive value on advance hodgkin lymphoma treatment outcome of end‐of treatment FDG PET/CT in the HD0607 clinical trial

Hematological oncology, 2023-08, Vol.41 (3), p.415-423

2023

Volltextzugriff (PDF)

The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study

Bone marrow transplantation (Basingstoke), 2021-01, Vol.56 (1), p.20-29

2021

Volltextzugriff (PDF)

Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second‐generation tyrosine kinase inhibitors in the real‐life practice: Identification of risk factors and the role of prophylaxis

American journal of hematology, 2018-07, Vol.93 (7), p.E159-E161

2018

Volltextzugriff (PDF)

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

Annals of hematology, 2021-05, Vol.100 (5), p.1213-1219

2021

Volltextzugriff (PDF)

Systemic mastocytosis with associated BCRABL1-negative atypical chronic myeloid leukemia

Annals of hematology, 2020-02, Vol.99 (2), p.363-365

2020

Volltextzugriff (PDF)

The Direct and Indirect Effects of Tyrosine Kinase Inhibitors on the Cardiovascular System in Chronic Myeloid Leukemia

Hemato, 2023-07, Vol.4 (3), p.207-226

2023

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Aktive Filter

KollektionSingle Journals

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(82)

Sprache

Englisch
(82)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(80)
Life Sciences & Biomedicine
(78)
Humans
(51)
Oncology
(44)
Male
(36)
Female
(33)
Adult
(30)
Middle Aged
(28)
Aged
(23)
Medicine
(20)
Medicine & Public Health
(19)
Aged, 80 And Over
(16)
Leukemia
(16)
Treatment Outcome
(15)
Chronic Myeloid Leukemia
(13)
Young Adult
(13)
Adolescent
(11)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(11)
Letter To The Editor
(9)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Could there be Haemodynamic Stress Effects on Pro-Inflammatory CD14+CD16+ Monocytes during Convective-Diffusive Treatments? A Prospective Randomized Controlled Trial

Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical setting

Prognostic Role of Cell Blood Count in Chronic Myeloid Neoplasm and Acute Myeloid Leukemia and Its Possible Implications in Hematopoietic Stem Cell Transplantation

Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?

High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity

Multifactorial pathogenesis of COVID‐19‐related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?

Defibrotide in the COVID‐19 coagulopathy: What is the timing?

A Real-World Study on Clofarabine and Cytarabine Combination in Patients with Relapsed/Refractory Acute Myeloid Leukemia

What Unrelated Hematopoietic Stem Cell Transplantation in Thalassemia Taught us about Transplant Immunogenetics

The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma

Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis

Perls Stain Grade in Bone Marrow Aspirate Correlates with Overall Survival in Low-Risk Myelodysplastic Patients

Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia

KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation

Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real‐life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart

Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomy

Bone Marrow Homing and Engraftment Defects of Human Hematopoietic Stem and Progenitor Cells

Combination Therapy with Ruxolitinib and Hydroxyurea for the Treatment of Myeloid-Predominant Leukocytosis in a Patient with Myelofibrosis

Rituximab Monotherapy or in Combination with Bendamustine Is Not Inferior to Rituximab-CHOP Regimen in the Treatment of Patients with Splenic Marginal Zone Lymphoma in the Real Life

Predictive value on advance hodgkin lymphoma treatment outcome of end‐of treatment FDG PET/CT in the HD0607 clinical trial

The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study

Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second‐generation tyrosine kinase inhibitors in the real‐life practice: Identification of risk factors and the role of prophylaxis

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

Systemic mastocytosis with associated BCRABL1-negative atypical chronic myeloid leukemia

The Direct and Indirect Effects of Tyrosine Kinase Inhibitors on the Cardiovascular System in Chronic Myeloid Leukemia

Aktive Filter

Suchergebnisse filtern